Vir Biotechnology, Inc.
VIR
$5.63
-$0.44-7.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.32% | -13.91% | -7.08% | 15.14% | 11.21% |
| Total Depreciation and Amortization | -27.76% | -35.18% | -29.57% | -25.15% | -4.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.51% | -50.32% | -20.10% | 18.91% | 66.13% |
| Change in Net Operating Assets | 63.05% | 101.02% | 106.26% | 72.64% | 30.25% |
| Cash from Operations | 2.81% | -1.43% | 45.56% | 42.69% | 26.60% |
| Capital Expenditure | -0.73% | -19.97% | 54.94% | 64.25% | 79.02% |
| Sale of Property, Plant, and Equipment | 207.31% | 205.48% | 485.37% | -- | 4,268.18% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.88% | 440.28% | 442.37% | 170.52% | 74.40% |
| Cash from Investing | 43.59% | 480.39% | 529.43% | 203.33% | 118.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.00% | 32.84% | 8,333.33% | -- | 172.20% |
| Issuance of Common Stock | -14.10% | -19.04% | -13.17% | -41.38% | -37.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.69% | -32.94% | 11.37% | -19.51% | -- |
| Cash from Financing | -16.57% | -22.04% | -8.59% | -41.34% | -38.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.10% | 97.05% | 128.32% | 109.46% | 59.34% |